MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Gastroenterology

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2008.04.003PMID 18555017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review

  2007cited by this paper
• Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.

  2007cited by this paper
• Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

  2007cited by this paper
• Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas

  2007cited by this paper
• Reversal of Stathmin-Mediated Resistance to Paclitaxel and Vinblastine in Human Breast Carcinoma Cells

  2007cited by this paper
• Protumorigenic overexpression of stathmin/Op18 by gain‐of‐function mutation in p53 in human hepatocarcinogenesis

  2007cited by this paper
• MicroRNA‐223 is a key factor in osteoclast differentiation

  2007cited by this paper
• Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression

  2007cited by this paper
• Neoplasms of the liver

  2007cited by this paper
• Cyclin G 1 Is a Target of miR-122 a , a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

  2007cited by this paper
• An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling.

  2007cited by this paper
• Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

  2007cited by this paper
• Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

  2006cited by this paper
• MicroRNAs modulate the angiogenic properties of HUVECs.

  2006cited by this paper
• Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions

  2006cited by this paper
• Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

  2006cited by this paper
• Cell-type-specific signatures of microRNAs on target mRNA expression.

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.

  2006cited by this paper
• Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues

  2006cited by this paper
• microRNA target predictions in animals

  2006cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• Expression profiling identifies microRNA signature in pancreatic cancer

  2006cited by this paper
• Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma

  2006cited by this paper
• A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.

  2006cited by this paper
• Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

  2006cited by this paper
• Treatment of hepatocellular carcinoma.

  2006cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

  2005cited by this paper
• Epidemiology of hepatocellular carcinoma.

  2005cited by this paper
• Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma

  2005cited by this paper
• Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

  2005cited by this paper
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005cited by this paper
• The role of microRNA genes in papillary thyroid carcinoma.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells.

  2005cited by this paper
• MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

  2004cited by this paper
• The role of stathmin in the regulation of the cell cycle

  2004cited by this paper
• Clinicopathologic significance of genetic alterations in hepatocellular carcinoma.

  2003cited by this paper
• MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

  2003cited by this paper
• Reduced accumulation of specific microRNAs in colorectal neoplasia.

  2003cited by this paper
• Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

  2003cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells

  2001cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Treatment of hepatocellular carcinoma

  1997cited by this paper
• Epidemiology of hepatocellular carcinoma.

  1995cited by this paper
• Characterization of cell lines established from human hepatocellular carcinoma

  1995cited by this paper
• Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells.

  1993cited by this paper
• Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma.

  1992cited by this paper
• [Epidemiology of hepatocellular carcinoma].

  1991cited by this paper
• Involvement of OP18 in cell proliferation.

  1991cited by this paper
• Prognosis of Primary Hepatocellular Carcinoma

  1984cited by this paper

• Hematological parameters in hepatocellular carcinoma AND microRNA-223 gene associated with Hepatitis virus in local area

  2026cites this paper
• Circulating microRNAs Expression as Prognosis Biomarker of Cholangiocarcinoma.

  2026cites this paper
• Colorectal cancer stem cells develop NK cell resistance via homotypic cell-in-cell structures suppressed by Stathmin1

  2025cites this paper
• Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters.

  2025cites this paper
• Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment

  2024cites this paper
• miRNAs in HCC, pathogenesis, and targets.

  2024cites this paper
• Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis

  2024cites this paper
• Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview

  2024influential citation
• Clinical significance of exosomal noncoding RNAs in hepatocellular carcinoma: a narrative review

  2024cites this paper
• Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma

  2024cites this paper
• MicroRNA-223: a key regulator of liver tumour microenvironment

  2023cites this paper
• miRNome of Child A hepatocellular carcinoma in Egyptian patients

  2023cites this paper
• HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article

  2023cites this paper
• Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma

  2023cites this paper
• STNM1 in human cancers: role, function and potential therapy sensitizer.

  2023cites this paper
• Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma

  2023cites this paper
• MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression

  2023cites this paper
• Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells

  2023cites this paper
• A six-miRNA signature as a novel biomarker for improving prediction of prognosis and patterns of immune infiltration in hepatocellular carcinoma.

  2022cites this paper
• Capsaicin Alters the Expression of Genetic and Epigenetic Molecules In Hepatocellular Carcinoma Cell

  2022cites this paper
• MiR-223 as a Regulator and Therapeutic Target in Liver Diseases

  2022cites this paper
• Non-coding RNA and hepatitis B virus-related hepatocellular carcinoma: A bibliometric analysis and systematic review

  2022cites this paper
• Micro-Players of Great Significance—Host microRNA Signature in Viral Infections in Humans and Animals

  2022cites this paper
• Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker

  2022cites this paper
• Hepatocellular Carcinoma: The Role of MicroRNAs

  2022cites this paper
• Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy

  2022cites this paper
• MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3

  2022cites this paper
• Computational Analysis of Single Nucleotide Polymorphisms Associated with MicroRNA Affecting Hepatitis B Infection.

  2022cites this paper
• hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection

  2022cites this paper
• miR-4730 suppresses the progression of liver cancer by targeting the high mobility group A1 pathway

  2022cites this paper
• MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway

  2022cites this paper
• Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer

  2022cites this paper
• Physical Activity as a Preventive Lifestyle Intervention Acts Through Specific Exosomal miRNA Species—Evidence From Human Short- and Long-Term Pilot Studies

  2021cites this paper
• Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma.

  2021cites this paper
• MicroRNA-223-5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1

  2021cites this paper
• microRNA-145-5p Inhibits Migration, Invasion, and Metastasis in Hepatocellular Carcinoma by Inhibiting ARF6

  2021influential citation
• Investigating the Role of miR-223 and INF-α in Iraqi HBV Patients

  2021cites this paper
• CMAR_A_300678 3473..3484

  2021influential citation
• The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response

  2021cites this paper
• MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma

  2021cites this paper
• MiRNA-223-3p Affects Mantle Cell Lymphoma Development by Regulating the CHUK/NF-ƘB2 Signaling Pathway

  2021cites this paper
• Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers

  2021cites this paper
• Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.

  2021cites this paper
• MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

  2021cites this paper
• From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis

  2021influential citation
• Retraction Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target

  2021cites this paper
• High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer

  2021cites this paper
• Large-scale identification of RBP-RNA interactions by RAPseq refines essentials of post-transcriptional gene regulation

  2021cites this paper
• The role of non-coding RNAs in chemotherapy for gastrointestinal cancers

  2021cites this paper
• The microRNA-210-Stathmin1 Axis Decreases Cell Stiffness to Facilitate the Invasiveness of Colorectal Cancer Stem Cells

  2021cites this paper
• MicroRNA-30e and MicroRNA-223 Expression for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C Virus

  2020cites this paper
• Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus–related hepatocellular carcinoma

  2020cites this paper
• Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma

  2020cites this paper
• MicroRNAs in Cancer: From Diagnosis to Therapeutics

  2020cites this paper
• microRNA-1915-3p Promotes Cell Metastasis and Progression by Targeting Bcl2L11 in Hepatocellular Carcinoma

  2020cites this paper
• Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils

  2020cites this paper
• MiR-381-3p inhibits proliferation, invasion and migration of hepatocellular carcinoma

  2020cites this paper
• MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma

  2020cites this paper
• The role of microRNA-210-3p in hepatitis B virus-relatedhepatocellular carcinoma.

  2020cites this paper
• Lipolytic Gene DAGLA is Targeted by miR-223 in Chicken Hepatocytes.

  2020cites this paper
• Long noncoding RNA DLGAP1‐AS1 promotes cell proliferation in hepatocellular carcinoma via sequestering miR‐486‐5p

  2020cites this paper
• EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1

  2020cites this paper
• Brain Tumor-Derived Extracellular Vesicles as Carriers of Disease Markers: Molecular Chaperones and MicroRNAs

  2020cites this paper
• Novel miRNA signature for predicting the stage of hepatocellular carcinoma

  2020cites this paper
• Optimized platelet rich plasma releasate (O-rPRP) repairs galactosemia-induced ovarian follicular loss in rats by activating mTOR signaling and inhibiting apoptosis

  2020cites this paper
• MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases

  2020cites this paper
• MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers

  2020cites this paper
• The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker.

  2020cites this paper
• Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets

  2020cites this paper
• Aberrant Expressional Profiling of Known MicroRNAs in the Liver of Silver Carp (Hypophthalmichthys molitrix) Following Microcystin-LR Exposure Based on samllRNA Sequencing

  2020cites this paper
• MicroRNA‐223 in gastrointestinal cancers: A systematic review and diagnostic meta‐analysis

  2020cites this paper
• miRNAs and Hepatocellular Carcinoma

  2020cites this paper
• Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.

  2019cites this paper
• Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway.

  2019cites this paper
• miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8

  2019cites this paper
• Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.

  2019cites this paper
• Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer.

  2019cites this paper
• miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells

  2019cites this paper
• Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells

  2019cites this paper
• Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma

  2019influential citation
• MicroRNAs as important regulators of the NLRP3 inflammasome.

  2019cites this paper
• SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.

  2019cites this paper
• MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes

  2019cites this paper
• Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review

  2019cites this paper
• miRNA-223 at the crossroads of inflammation and cancer.

  2019cites this paper
• Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway

  2018influential citation
• microRNAs: Key players in virus‐associated hepatocellular carcinoma

  2018cites this paper
• Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human

  2018cites this paper
• Transcriptional landscapes of Axolotl (Ambystoma mexicanum).

  2018cites this paper
• EBV‐encoded miRNAs target ATM‐mediated response in nasopharyngeal carcinoma

  2018cites this paper
• Research advancement in the tumor biomarker of hepatocellular carcinoma

  2018cites this paper
• microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.

  2018cites this paper
• Role of miR-223 in the pathophysiology of liver diseases

  2018cites this paper
• Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression.

  2018cites this paper
• MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas.

  2018cites this paper
• MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer

  2018cites this paper
• MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation

  2018cites this paper
• The impact of metformin on cardiovascular markers in type 1 diabetes :MERIT study

  2018cites this paper
• miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis

  2018cites this paper
• miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker

  2018cites this paper